Lucid Diagnostics (LUCD) Payables (2021 - 2025)
Lucid Diagnostics (LUCD) has disclosed Payables for 5 consecutive years, with $24.6 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Payables rose 116.82% year-over-year to $24.6 million, compared with a TTM value of $24.6 million through Sep 2025, up 116.82%, and an annual FY2024 reading of $21.4 million, up 41.95% over the prior year.
- Payables was $24.6 million for Q3 2025 at Lucid Diagnostics, down from $26.1 million in the prior quarter.
- Across five years, Payables topped out at $33.6 million in Q1 2025 and bottomed at $307533.0 in Q3 2021.
- Average Payables over 5 years is $12.5 million, with a median of $14.1 million recorded in 2023.
- The sharpest move saw Payables surged 1305.08% in 2023, then decreased 26.8% in 2024.
- Year by year, Payables stood at $1.1 million in 2021, then skyrocketed by 30.01% to $1.4 million in 2022, then skyrocketed by 943.26% to $15.1 million in 2023, then soared by 41.95% to $21.4 million in 2024, then increased by 14.69% to $24.6 million in 2025.
- Business Quant data shows Payables for LUCD at $24.6 million in Q3 2025, $26.1 million in Q2 2025, and $33.6 million in Q1 2025.